PCM
WVE icon

Pavaki Capital Management’s Wave Life Sciences WVE Stock Holding History

Pavaki Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.2K Hold
15,000
– – 0.03% 159
2026
Q1 		$109K Buy
+15,000
New +$195K 0.05% 148

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Pavaki Capital Management's WVE Position: Q2 2026 in Review

Pavaki Capital Management held its Wave Life Sciences (WVE) position steady in Q2 2026 at 15,000 shares worth $87.2K. The position accounts for 0.03% of the portfolio, ranked #159.

Pavaki Capital Management first reported a position in WVE in Q1 2026 and has held it in 2 quarters since. The position peaked at $109K in Q1 2026. 221 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Pavaki Capital Management held 15,000 shares of Wave Life Sciences worth $87.2K as of Q2 2026.
  • Pavaki Capital Management left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up 0.03% of Pavaki Capital Management's portfolio in Q2 2026, its #159 holding.
  • Pavaki Capital Management first reported a position in Wave Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Pavaki Capital Management's Wave Life Sciences position peaked at $109K in Q1 2026.
  • 221 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Pavaki Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.